Cargando…

China's NMPA perspective on the clinical performance of SARS-CoV-2 antigen test reagents

The COVID-19 pandemic continues to spread all over the world. In the process of emergency use authorization, the Center for Medical Device Evaluation of the China National Medical Products Administration issued ‘Key Points of Technical Review for the Registration of SARS-CoV-2 Antigen/Antibody Detec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lv, Yunfeng, Gao, Yu, He, Jingyun, Xu, Chao, Liu, Rongzhi, Zheng, Shengwei, Fang, Li, Han, Congyin, Li, Ran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Newlands Press Ltd 2022
Materias:	Regulatory
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860178/ https://www.ncbi.nlm.nih.gov/pubmed/35188408 http://dx.doi.org/10.4155/bio-2021-0176

Ejemplares similares

China NMPA perspective on clinical evaluation of SARS-CoV-2 antibody test reagents in the process of emergency approval
por: Lv, Yunfeng, et al.
Publicado: (2020)

Key points of technical review for the registration of SARS-CoV-2 antigen/antibody tests
por: Li, Hongran, et al.
Publicado: (2021)

Key points of technical review for the registration of SARS-CoV-2 nucleic acid tests in China
por: Li, Hongran, et al.
Publicado: (2021)

Drug Lag and Key Regulatory Barriers in the Emerging Markets
por: Wileman, Harriet, et al.
Publicado: (2010)

Regulations and guidelines governing stem cell based products: Clinical considerations
por: George, Bobby
Publicado: (2011)

Regulatory Considerations for Biosimilars
por: Nellore, Ranjani
Publicado: (2010)

Registration of Medical Devices
por: George, Bobby
Publicado: (2010)

Implications of ICH-E5: Assessment of drug's sensitivity to ethnic factors and necessity of a bridging study for global drug development
por: Gupta, Sandeep Kumar
Publicado: (2011)

Regulatory requirements for marketing fixed dose combinations
por: Jayasheel, B. G.
Publicado: (2010)

Injury and death in clinical trials and compensation: Rule 122 DAB
por: Ghooi, Ravindra. B.
Publicado: (2013)

Novel targeted drugs approved by the NMPA and FDA in 2019
por: Wang, Wenjing, et al.
Publicado: (2020)

Investigation of Temperature Cycling with Coupled Vessels for Efficient Deracemization of NMPA
por: Rehman, Ghufran ur, et al.
Publicado: (2023)

Value assessment of NMPA-approved new cancer drugs for solid cancer in China, 2016–2020
por: Luo, Jing, et al.
Publicado: (2023)

Standardisation of defined approaches for skin sensitisation testing to support regulatory use and international adoption: position of the International Cooperation on Alternative Test Methods
por: Casati, S., et al.
Publicado: (2017)

An approach for mixture testing and prioritization based on common kinetic groups
por: Braeuning, Albert, et al.
Publicado: (2022)

A new conceptional model for deriving average dermal absorption estimates from studies with multiple tested concentrations for non-dietary risk assessment of pesticides
por: Kluxen, Felix M., et al.
Publicado: (2022)

Next generation risk assessment of human exposure to estrogens using safe comparator compound values based on in vitro bioactivity assays
por: van Tongeren, Tessa C. A., et al.
Publicado: (2023)

FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell‐Induced Severe or Life‐Threatening Cytokine Release Syndrome
por: Le, Robert Q., et al.
Publicado: (2018)

Modernizing persistence–bioaccumulation–toxicity (PBT) assessment with high throughput animal-free methods
por: Escher, Beate I., et al.
Publicado: (2023)

Screening of chemicals for human bioaccumulative potential with a physiologically based toxicokinetic model
por: Tonnelier, Arnaud, et al.
Publicado: (2011)

Indian Regulatory Update: Jan-May 2014
por: Suvarnapathaki, Kedar
Publicado: (2014)

Sensory irritation as a basis for setting occupational exposure limits
por: Brüning, Thomas, et al.
Publicado: (2014)

Indian Regulatory Update: June-August 2014
por: Suvarnapathaki, Kedar
Publicado: (2014)

Indian regulatory update 2013
por: Suvarnapathaki, Kedar
Publicado: (2013)

Indian Regulatory Update: September-November 2013
por: Suvarnapathaki, Kedar
Publicado: (2014)

Indian Regulatory Update: January-March 2015
por: Suvarnapathaki, Kedar
Publicado: (2015)

Good Clinical Practice Training: Identifying Key Elements and Strategies for Increasing Training Efficiency
por: Arango, Jaime, et al.
Publicado: (2016)

Translating New Science Into the Drug Review Process: The US FDA’s Division of Applied Regulatory Science
por: Rouse, Rodney, et al.
Publicado: (2017)

Indian Regulatory Update: January-December 2017
por: Bhave, Amita
Publicado: (2018)

Predicting in vivo effect levels for repeat-dose systemic toxicity using chemical, biological, kinetic and study covariates
por: Truong, Lisa, et al.
Publicado: (2017)

Indian Regulatory Update: January – March 2018
por: Bhave, Amita
Publicado: (2018)

Current pesticide dietary risk assessment in light of comparable animal study NOAELs after chronic and short-termed exposure durations
por: Zarn, Jürg A., et al.
Publicado: (2017)

Advancing a Framework for Regulatory Use of Real-World Evidence: When Real Is Reliable
por: Dreyer, Nancy A.
Publicado: (2018)

Indian regulatory update April–October 2018
por: Bhave, Amita, et al.
Publicado: (2019)

A framework for the use of single-chemical transcriptomics data in predicting the hazards associated with complex mixtures of polycyclic aromatic hydrocarbons
por: Labib, Sarah, et al.
Publicado: (2016)

Recommended approaches in the application of toxicogenomics to derive points of departure for chemical risk assessment
por: Farmahin, Reza, et al.
Publicado: (2016)

Screening of repeated dose toxicity data in safety evaluation reports of cosmetic ingredients issued by the Scientific Committee on Consumer Safety between 2009 and 2019
por: Gustafson, Emma, et al.
Publicado: (2020)

Indian regulatory update during the COVID-19 pandemic
por: Bhave, Amita Chandan
Publicado: (2020)

Survey of Japanese Orphan Drug Program: Factors Related to Successful Marketing Approval
por: Harada, Kenji, et al.
Publicado: (2019)

Indian Regulatory Update-2 during the COVID-19 pandemic
por: Bhave, Amita
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k2qg673ushppavpk86ar00ikhp